Scabies mite intestinal proteases as targets for novel therapeutics.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1067192

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Scabies causes bacterial disease affecting poor people worldwide. Available therapies are limited and drug resistance is emerging. We investigate molecules that the mite needs to infest the skin, to guide the formulation and the testing of novel drugs. This will provide improved treatment of affected individuals and their families, thereby reducing the spread of scabies and bacterial infections and their devastating sequelae, particularly in Australian Indigenous communities.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $672,533.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Parasitology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Aboriginal health | animal model | drug discovery | protease | protease inhibitors | scabies | skin infections

Related Links